Ion Beam Applications SA (IOBCF)
USD 11.5
(5.02%)
USD 11.5
(5.02%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 490.44 Million EUR | -3.45% |
| 2022 | 507.94 Million EUR | 20.9% |
| 2021 | 420.15 Million EUR | 13.81% |
| 2020 | 369.16 Million EUR | 17.66% |
| 2019 | 313.76 Million EUR | 8.56% |
| 2018 | 289.03 Million EUR | 29.14% |
| 2017 | 223.82 Million EUR | -2.78% |
| 2016 | 230.22 Million EUR | -0.64% |
| 2015 | 231.72 Million EUR | 16.13% |
| 2014 | 199.53 Million EUR | -6.99% |
| 2013 | 214.51 Million EUR | -34.71% |
| 2012 | 328.53 Million EUR | -23.47% |
| 2011 | 429.29 Million EUR | 14.23% |
| 2010 | 375.8 Million EUR | 12.01% |
| 2009 | 335.5 Million EUR | -6.06% |
| 2008 | 357.15 Million EUR | 95.21% |
| 2007 | 182.95 Million EUR | 40.16% |
| 2006 | 130.53 Million EUR | 32.02% |
| 2005 | 98.87 Million EUR | -38.43% |
| 2004 | 160.6 Million EUR | -49.72% |
| 2003 | 319.4 Million EUR | -11.28% |
| 2002 | 360 Million EUR | -6.96% |
| 2001 | 386.93 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 505.87 Million EUR | 0.0% |
| 2024 Q1 | 505.87 Million EUR | 3.15% |
| 2023 Q3 | 491.31 Million EUR | -6.12% |
| 2023 Q2 | 523.33 Million EUR | 0.0% |
| 2023 Q1 | 523.33 Million EUR | 3.03% |
| 2023 Q4 | 490.44 Million EUR | -0.18% |
| 2023 FY | 490.44 Million EUR | -3.45% |
| 2022 Q1 | 452.8 Million EUR | 7.77% |
| 2022 Q4 | 507.94 Million EUR | 0.0% |
| 2022 FY | 507.94 Million EUR | 20.9% |
| 2022 Q3 | 507.94 Million EUR | 12.18% |
| 2022 Q2 | 452.8 Million EUR | 0.0% |
| 2021 Q4 | 420.15 Million EUR | 0.0% |
| 2021 Q3 | 420.15 Million EUR | 15.51% |
| 2021 Q1 | 363.73 Million EUR | -1.47% |
| 2021 FY | 420.15 Million EUR | 13.81% |
| 2021 Q2 | 363.73 Million EUR | 0.0% |
| 2020 Q1 | 342.74 Million EUR | 9.24% |
| 2020 Q2 | 342.74 Million EUR | 0.0% |
| 2020 Q3 | 369.16 Million EUR | 7.71% |
| 2020 Q4 | 369.16 Million EUR | 0.0% |
| 2020 FY | 369.16 Million EUR | 17.66% |
| 2019 FY | 313.76 Million EUR | 8.56% |
| 2019 Q4 | 313.76 Million EUR | 0.0% |
| 2019 Q1 | 293.74 Million EUR | 1.63% |
| 2019 Q3 | 313.76 Million EUR | 6.82% |
| 2019 Q2 | 293.74 Million EUR | 0.0% |
| 2018 Q1 | 261.55 Million EUR | 16.86% |
| 2018 FY | 289.03 Million EUR | 29.14% |
| 2018 Q4 | 289.03 Million EUR | -4.97% |
| 2018 Q3 | 304.15 Million EUR | 16.29% |
| 2018 Q2 | 261.55 Million EUR | 0.0% |
| 2017 Q3 | 223.82 Million EUR | 1.16% |
| 2017 Q2 | 221.24 Million EUR | 0.0% |
| 2017 Q1 | 221.24 Million EUR | -3.9% |
| 2017 Q4 | 223.82 Million EUR | 0.0% |
| 2017 FY | 223.82 Million EUR | -2.78% |
| 2016 Q1 | 235.43 Million EUR | 1.6% |
| 2016 Q3 | 230.22 Million EUR | -2.21% |
| 2016 FY | 230.22 Million EUR | -0.64% |
| 2016 Q2 | 235.43 Million EUR | 0.0% |
| 2016 Q4 | 230.22 Million EUR | 0.0% |
| 2015 Q1 | 206.78 Million EUR | 3.63% |
| 2015 Q4 | 231.72 Million EUR | -1.29% |
| 2015 FY | 231.72 Million EUR | 16.13% |
| 2015 Q2 | 206.78 Million EUR | 0.0% |
| 2015 Q3 | 234.75 Million EUR | 13.53% |
| 2014 Q2 | 209.01 Million EUR | 0.0% |
| 2014 Q3 | 199.53 Million EUR | -4.54% |
| 2014 Q4 | 199.53 Million EUR | 0.0% |
| 2014 Q1 | 209.01 Million EUR | -2.57% |
| 2014 FY | 199.53 Million EUR | -6.99% |
| 2013 FY | 214.51 Million EUR | -34.71% |
| 2013 Q4 | 214.51 Million EUR | 0.0% |
| 2013 Q3 | 214.51 Million EUR | -20.97% |
| 2013 Q2 | 271.43 Million EUR | 0.0% |
| 2013 Q1 | 271.43 Million EUR | -17.38% |
| 2012 FY | 328.53 Million EUR | -23.47% |
| 2012 Q4 | 328.53 Million EUR | 0.0% |
| 2012 Q3 | 328.53 Million EUR | -5.65% |
| 2012 Q2 | 348.22 Million EUR | 0.0% |
| 2011 Q2 | 420.16 Million EUR | 0.0% |
| 2011 FY | 429.29 Million EUR | 14.23% |
| 2011 Q4 | 429.29 Million EUR | 0.0% |
| 2010 FY | 375.8 Million EUR | 12.01% |
| 2010 Q4 | 375.8 Million EUR | 0.0% |
| 2010 Q2 | 379.11 Million EUR | 0.0% |
| 2009 Q4 | 335.5 Million EUR | 0.0% |
| 2009 FY | 335.5 Million EUR | -6.06% |
| 2008 FY | 357.15 Million EUR | 95.21% |
| 2007 FY | 182.95 Million EUR | 40.16% |
| 2006 FY | 130.53 Million EUR | 32.02% |
| 2005 FY | 98.87 Million EUR | -38.43% |
| 2004 FY | 160.6 Million EUR | -49.72% |
| 2003 FY | 319.4 Million EUR | -11.28% |
| 2002 FY | 360 Million EUR | -6.96% |
| 2001 FY | 386.93 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| IR-Med Inc. | 634 Thousand USD | -77257.413% |
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 16.62 Million USD | -2850.44% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -72278.161% |
| Polarean Imaging plc | 2.58 Million USD | -18905.564% |
| Avitar, Inc. | 11.59 Million USD | -4130.34% |
| AVITA Medical, Inc. | 19.86 Million USD | -2368.845% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | -23056.091% |
| Össur hf. | 688.8 Million USD | 28.798% |
| Zecotek Photonics Inc. | 5.86 Million USD | -8257.112% |
| QHSLab, Inc. | 2.05 Million USD | -23742.213% |
| Wellstar International, Inc. | 55.99 Million USD | -775.944% |
| Össur hf. | 688.8 Million USD | 28.798% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | -2949.936% |
| Escalon Medical Corp. | 2.94 Million USD | -16534.632% |
| Aurora Spine Corporation | 6.65 Million USD | -7271.208% |
| BrainsWay Ltd. | 15.31 Million USD | -3102.599% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 6.01 Million USD | -8056.907% |
| Hamilton Thorne Ltd. | 45.84 Million USD | -969.842% |
| Vivos Inc. | 245 Thousand USD | -200078.773% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 80.275% |
| Kelyniam Global, Inc. | 1.01 Million USD | -48318.309% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -177846.694% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | -19919.773% |
| Nanomix Corporation | 14.81 Million USD | -3210.526% |
| Theraclion SA | 13.01 Million EUR | -3667.859% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | -9471.178% |
| Positron Corporation | 2.02 Million USD | -24107.625% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | -13443.855% |
| Lombard Medical, Inc. | 53.79 Million USD | -811.711% |
| ALR Technologies Inc. | 24.5 Million USD | -1901.383% |
| Stratec SE | 271.97 Million USD | -80.331% |
| Vycor Medical, Inc. | 4.31 Million USD | -11258.77% |
| Heart Tronics, Inc. | 1.09 Million USD | -44698.221% |
| Nu-Med Plus, Inc. | 2.35 Million USD | -20692.306% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | -8855.356% |
| SANUWAVE Health, Inc. | 65.59 Million USD | -647.699% |
| VMS Rehab Systems, Inc. | 201.36 USD | -243566646.126% |
| Guided Therapeutics, Inc. | 5.47 Million USD | -8857.918% |
| Ingen Technologies, Inc. | 5.7 Million USD | -8489.928% |
| Odyssey Group International, Inc. | 6.61 Million USD | -7317.825% |
| United American Healthcare Corporation | 119 Thousand USD | -412039.496% |
| ECGI Holdings, Inc. | 11.94 Million USD | -4007.464% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -36943.197% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -33809.525% |
| Urologix, Inc. | 12.64 Million USD | -3778.883% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -8988.96% |
| Nexeon MedSystems Inc. | 8.48 Million USD | -5681.887% |
| SS Innovations International, Inc. | 11.18 Million USD | -4286.383% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -93249.474% |
| Smith & Nephew plc | 4.76 Billion USD | 89.704% |
| NIOX Group Plc | 9.8 Million USD | -4903.479% |
| Fuse Medical, Inc. | 15.11 Million USD | -3145.823% |
| Broncus Holding Corporation | 10.43 Million USD | -4601.285% |
| Brain Scientific Inc. | 7.42 Million USD | -6504.085% |
| Pressure BioSciences, Inc. | 33.8 Million USD | -1350.873% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -61662.717% |